Table 2.
Association of RSV test result with characteristics of study patients in selected health facilities in Ethiopia, May 2023-April 2024
| Description | RSV test result | COR (95%CI) | P-value | AOR (95%CI) | P-value | |||
|---|---|---|---|---|---|---|---|---|
| Negative (%) | Positive (%) | Total | ||||||
| Sex | Male | 1896(84.0) | 362(16.0) | 2256 | 1.06(0.90–1.26) | 0.490 | N/A | |
| Female | 1622(84.7) | 292(15.3) | 1914 | Ref | ||||
| Age-group(years) | <2 | 1231(73.4) | 446(26.6) | 1675 | 10.64(4.68-24.19) | <0.001 | 8.20(3.57-18.81) | <0.001* |
| 2-4 | 604(81.7) | 135(18.3) | 739 | 6.56(2.85-15.11) | <0.001 | 5.01(2.15-11.67) | <0.001* | |
| 5-14 | 529(91.8) | 47(8.2) | 576 | 2.61(1.10-6.20) | 0.030 | 1.91(0.79-4.60) | 0.150 | |
| 15-49 | 792(98.3) | 14(1.7) | 806 | 0.52(0.20–1.37) | 0.185 | 0.42(0.16-1.13) | 0.090 | |
| 50-64 | 186(96.9) | 6(3.1) | 192 | 0.95(0.30-2.99) | 0.925 | 0.84(0.27-2.69) | 0.77 | |
| >65 | 176(96.7) | 6(3.3) | 182 | Ref | ||||
| Admission Type | SARI | 2661(83.4) | 531(16.6) | 3190 | 1.39(1.13–1.72) | 0.002 | 1.18(0.90-1.55) | 0.242 |
| ILI | 857(87.4) | 123(12.6) | 980 | Ref | ||||
| Location | Addis Ababa | 1428(83.0) | 294(17.1) | 1722 | 1.19(1.01–1.41) | 0.039 | 1.06(0.85-1.31) | 0.632 |
| Regions | 2090(85.3) | 360(14.7) | 2450 | Ref | ||||
| Season (months) | Autumn (Sep, Oct, Nov) | 1356(76.2) | 425(23.8) | 1788 | 6.08(3.96-9.41) | <0.001 | 5.89(3.79-9.17) | <0.001* |
| Spring (Mar, Apr, May) | 693(96.1) | 28(3.9) | 722 | 0.79(0.45-1.39) | 0.411 | 0.80(0.47-1.42) | 0.440 | |
| Winter (Dec, Jan, Feb) | 1018(85.0) | 178(15.0) | 1187 | 3.45(2.21-5.40) | <0.001 | 3.27(2.07-5.16) | <0.001* | |
| Summer (Jun, Jul, Aug) | 451(95.1) | 23(4.9) | 473 | Ref | ||||
| DUR† (days) | ≤3 | 1924(82.6) | 405(17.4) | 2329 | 1.89(1.22-2.95) | 0.005 | 1.76(1.09-2.84) | 0.020* |
| 4-7 | 1385(86.0) | 226(14.0) | 1611 | 1.47(0.93-2.31) | 0.096 | 1.37(0.84-2.22) | 0.200 | |
| 8-10 | 207(90.0) | 23(10.0) | 230 | Ref | ||||
| Total** | 3518(84.3) | 654(15.7) | 4170 | - | ||||
Key: SARI Severe acute respiratory illness, ILI Influenza like illness, COR Crude Odds Ratio, AOR Adjusted odds ratio, 95%CI 95% Confidence interval, DUR Duration in days from date of symptom onset to data of sample collection, N/A Not applicable
*RSV positivity is significantly associated with independent variables
**Overall RSV test positivity was 15.7% (95%CI: 14.6-16.8)
†DUR: adjusted for age